Sales Growth YoY (Last Twelve Months): Ascendis (ASND)

Graphic logo of Ascendis (ASND)

Ascendis Pharma A/S (ASND) is implementing the TransCon platform to replace daily injections with infrequent procedures. A technological moat and strong R&D ensure high product margins. Year-over-year sales growth (over 4 quarters) confirms the strategy's effectiveness, with the indicator remaining around 93.80. This trend helps the company capture the growth hormone market, radically transforming conventional drug delivery systems.

Sales Growth YoY (Last Twelve Months): Ascendis Pharma Inc. (ASND) for 02/11/2024 - 11/17/2026

ascendispharma.com (ASND) - metric breakdowns and financial figures

- market value and analyst target forecast:
- company stock exchange capitalization indicators:
Analysis of all company metrics:ASND Ascendis Pharma Inc.
Mass-produced product of Ascendis Pharma A/S

For Ascendis Pharma A/S (ASND), the commercialization dynamics of long-acting drugs in the US and Europe directly determine the pace of business scaling. By analyzing the year-over-year revenue growth rate over the TTM, investors track the rolling sales increase, which allows them to identify a fundamental reversal in demand and confirm the stability of cash flows prior to official reports, thereby eliminating the risk of capital freeze.

Who Ascendis Pharma A/S competes with

Madrigal Corp (MDGL) - Trailing Twelve Months Revenue Growth|CORT - Sales Growth YoY (Last Twelve Months)|RYTM: Sales Growth YoY (Last Twelve Months)|AKRO: Sales Growth YoY (TTM)|MTSR - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) MoonLake Corp|Crinetics Corp (CRNX) - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) newamsterdampharma.com (NAMS)|Revenue Growth YoY (Last 12 Months) soleno.life SLNO|Sales Growth YoY (TTM) FOLD (amicusrx.com)|Annual Revenue Growth (Last Twelve Months) 89bio (ETNB)|Agios - Sales Growth YoY (TTM)|Structure Corp - Revenue Change YoY (Last 12 Months)|mimedx.com (MDXG) - Sales Growth YoY (Last Twelve Months)|Trailing Twelve Months Sales Growth RZLT (rezolutebio.com)|LXRX (Lexicon Pharmaceuticals Inc) - Sales Growth YoY (TTM)|Sales Growth YoY (Last Twelve Months) MBX|Sales Growth YoY (Last Twelve Months) Altimmune Pharma (ALT)|Sales Growth YoY (Last Twelve Months) AARD (Aardvark Therapeutics Corp)|Sales Growth YoY (TTM) SGMT (Sagimet Biosciences, Inc.)|BioAge (BIOA) - Trailing Twelve Months Revenue Growth|BMEA: Revenue Growth YoY (Last 12 Months)|Revenue Dynamics YoY (Last Twelve Months) QNCX (Quince Therapeutics Inc)|GUTS (Fractyl) - Revenue Growth YoY (Last 12 Months)|vTv Therapeutics, Inc. - Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Agape ATP Corp.|Revenue Growth YoY (Last 12 Months) Pluri (PLUR)|Sales Growth YoY (TTM) SYBX|Annual Revenue Growth (Last Twelve Months) Lipocine Inc|Sales Growth YoY (Last Twelve Months) Matinas BioPharma Holdings MTNB|Annual Revenue Growth (Last Twelve Months) Spruce Biosciences (SPRB)|GLTO: Revenue Growth YoY (Last 12 Months)|Trailing Twelve Months Sales Growth CTCX|LUMO (Lumos Pharma) - Revenue Growth YoY (Last 12 Months)|Sales Growth YoY (Last 12 Months) ONVO|RDUS (Radius Pharmaceuticals) - Sales Growth YoY (TTM)